Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study.
第一作者:
Georgiana K,Ellis
第一单位:
Seattle Cancer Care Alliance, 825 Eastlake Avenue East, Mail Stop G3-200, Seattle, WA, 98109-1023, USA. gellis@u.washington.edu
作者:
主题词
吸收测定法, 光子(Absorptiometry, Photon);老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);芳香酶抑制剂(Aromatase Inhibitors);骨密度(Bone Density);乳腺肿瘤(Breast Neoplasms);化学疗法, 辅助(Chemotherapy, Adjuvant);综合疗法(Combined Modality Therapy);用药计划表(Drug Administration Schedule);雌激素类(Estrogens);女(雌)性(Female);股骨颈(Femur Neck);人类(Humans);腰椎(Lumbar Vertebrae);中年人(Middle Aged);肿瘤, 激素依赖性(Neoplasms, Hormone-Dependent);骨质疏松, 绝经后(Osteoporosis, Postmenopausal);RANK配体(RANK Ligand);他莫昔芬(Tamoxifen)
DOI
10.1007/s10549-009-0352-y
PMID
19308727
发布时间
2016-11-25
- 浏览33
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文